claim: fdaines the emergency use of chloroquine phosphate and hydroxychloroquine sulfate for treatment of covid-19
evidence_1: the u.s. food and drug administration (fda) issued an emergency use authorization (eua) to barda to allow hydroxychloroquine sulfate and resochin donated to the strategic national stockpile (sns) to be distributed and prescribed by doctors to hospitalized teen and adult patients with covid-19, as appropriate, when a clinical trial is not available or feasible.